Skip to ContentSkip to Navigation
About us Practical matters How to find us S.M. Hogeling

Publications

The identification of novel therapeutic targets in acute myeloid leukemia

Preclinical efficacy of the potent, selective menin-KMT2A inhibitor JNJ-75276617 (bleximenib) in KMT2A- and NPM1-altered leukemias

M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism

CombiFlow: combinatorial AML-specific plasma membrane expression profiles allow longitudinal tracking of clones

Dietary methionine starvation impairs acute myeloid leukemia progression

CombiFlow: Flow cytometry-based identification and characterization of genetically and functionally distinct AML subclones

CREB signaling activity correlates with differentiation and survival in medulloblastoma

The USP7-TRIM27 axis mediates non-canonical PRC1.1 function and is a druggable target in leukemia

Prospective Isolation and Characterization of Genetically and Functionally Distinct AML Subclones